CCL

Összesen 18 találat.
#/oldal:
Részletezés:
Rendezés:

1.

001-es BibID:BIBFORM092841
035-os BibID:(cikkazonosító)615177
Első szerző:Árokszállási Tamás (neurológus)
Cím:Prognostic value of various hemostasis parameters and neurophysiological examinations in spontaneous intracerebral hemorrhage : the IRONHEART study protocol / Tamás Árokszállási, Máté Héja, Zsuzsa Bagoly, Kitti Bernadett Kovács, Rita Kálmándi, Ferenc Sarkady, Judit Tóth, Klára Fekete, István Fekete, Laszlo Csiba
Dátum:2021
ISSN:1664-2295
Megjegyzések:Rationale: Stroke is the leading cause of death in all developed countries. In Hungary, more than 10000 patients die annually due to cerebrovascular diseases according to the WHO Mortality Database. 10-15 % of these patients suffer non-traumatic intracerebral hemorrhage (ICH). ICH results in a higher rate of mortality as compared to ischemic stroke and outcomes are difficult to predict. In the GINOP IRONHEART study, we aim to test various hemostasis parameters and clinical neurophysiological examinations in evaluating outcome in intracerebral haemorrhage. Methods: In this prospective, observational study, we plan to enroll consecutive patients with non-traumatic spontaneous intracerebral hemorrhage admitted to a single Stroke Center (Department of Neurology, University of Debrecen, Hungary). The protocol of the GINOP IRONHEART study includes the investigation of detailed clinical, laboratory investigations, and various neurophysiological examiniations. Stroke severity is quantified based on the National Institutes of Health Stroke Scale (NIHSS) on admisson and day 7, 14, 90 after the onset of stroke. Cranial CT is performed on admission, day 14, and 90 to estimate the ICH volume. Modified Rankin Score (mRS) is used for evaluating the long-term outcome (90 days post-event). Blood is drawn immediately on admission for specific hemostasis tests. Digital and quantitative EEG techniques and motor evoked potential (MEP) are performed to evaluate the prognosis of cerebral hemorrhage on admission (within 24-28h), immediately before discharge (??10?14 days later), and 3 months after the event. Outcomes: The following outcomes are investigated: 1/ Mortality by day 14 and day 90 2/ Long-term outcome at 90 days post-event: mRS 0-1 is defined as favorable long-term outcome. Discussion: If associations between outcomes and the investigated parameters (hemostasis and neurophysiological examinations) are confirmed, results might aid prognosis assessment in this subtype of stroke with particularly high mortality. Improving clinical grading systems on ICH severity and outcomes by including the investigated parameters could help to better guide the management of these patients in the future.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Frontiers in Neurology. - 12 (2021), p. 1-6. -
További szerzők:Héja Máté (1991-) (általános orvos) Bagoly Zsuzsa (1978-) (orvos) Kovács Kitti Bernadett (1985-) (neurológus) Orbán-Kálmándi Rita Angéla (1993-) (klinikai laboratóriumi kutató) Sarkady Ferenc (1982-) (laboratóriumi analitikus) Tóth Judit (1964-) (radiológus) Fekete Klára (1978-) (neurológus) Fekete István (1951-) (neurológus, pszichiáter) Csiba László (1952-) (neurológus, pszichiáter)
Pályázati támogatás:GINOP-2.3.2-15-2016-00043
GINOP
Internet cím:Intézményi repozitóriumban (DEA) tárolt változat
DOI
Borító:

2.

001-es BibID:BIBFORM096463
035-os BibID:(cikkazonosító)737556
Első szerző:Bagoly Zsuzsa (orvos)
Cím:Editorial : hemostasis and Stroke / Bagoly Zsuzsa, Behme Daniel, Kaesmacher Johannes, Martinez De Lizarrondo Sara
Dátum:2021
ISSN:1664-2295 1664-2295
Tárgyszavak:Orvostudományok Klinikai orvostudományok szerkesztőségi anyag
folyóiratcikk
Megjelenés:Frontiers in Neurology. - 12 (2021), p. 1-4. -
További szerzők:Behme, Daniel Kaesmacher, Johannes Martinez De Lizarrondo, Sara
Pályázati támogatás:FK128582
NKFIH
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

3.

001-es BibID:BIBFORM079710
035-os BibID:(cikkazonosító)513 (WOS)000472470100001 (Scopus)85069171973 (PMID)31316444
Első szerző:Bagoly Zsuzsa (orvos)
Cím:Markers of Coagulation and Fibrinolysis Predicting the Outcome of Acute Ischemic Stroke Thrombolysis Treatment : a Review of the Literature / Bagoly Zsuzsa, Szegedi István, Kálmándi Rita, Tóth Noémi Klára, Csiba László
Dátum:2019
ISSN:1664-2295
Tárgyszavak:Orvostudományok Elméleti orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
thrombolysis
coagulation
fibrinolysis
stroke
outcome
Megjelenés:Frontiers in Neurology. - 10 (2019), p. 1-13. -
További szerzők:Szegedi István (1992-) (orvos) Orbán-Kálmándi Rita Angéla (1993-) (klinikai laboratóriumi kutató) Tóth Noémi Klára Csiba László (1952-) (neurológus, pszichiáter)
Pályázati támogatás:NKFIH K109712, K120042, FK128582
Egyéb
GINOP-2.3.2-15-2016-00048
GINOP
GINOP-2.3.2-15-2016-00043
GINOP
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

4.

001-es BibID:BIBFORM106493
035-os BibID:(cikkazonosító)1080046 (scopus)85148346981 (wos)000932236400001
Első szerző:Fekete Klára (neurológus)
Cím:Predictors and long-term outcome of intracranial hemorrhage after thrombolytic therapy for acute ischemic stroke : A prospective single center study / Fekete Klára, Héja Máté, Márton Sándor, Tóth Judit, Horváth László, Harman Aletta, Fekete István
Dátum:2023
ISSN:1664-2295
Megjegyzések:Introduction: Acute ischemic stroke (AIS) is a potentially devastating disease with high disability and mortality. Recombinant tissue plasminogen activator (rt-PA) is an effective treatment with a 2-8% possible risk for symptomatic intracranial hemorrhage (sICH). Our aim was to investigate the risk factors and long-term clinical outcome of ICH in patients after rt-PA treatment. Methods: Consecutive patients with AIS, thrombolyzed at the Department of Neurology, University of Debrecen between January 1, 2004 and August 31, 2016 were enrolled prospectively. Risk factors, stroke severity based on the National Institute of Health Stroke Scale (NIHSS), functional outcome using modified Rankin-scale and mortality at one year were compared in patients with and without ICH following rt-PA treatment. We evaluated clinical characteristics and prognosis by hemorrhage type based on the Heidelberg Bleeding Classification. Descriptive statistics, ?2-test, Mann-Whitney U-test, ANOVA and Kruskal-Wallis-test, survival analysis, logistic regression were performed as appropriate. Results: Out of 1252 thrombolyzed patients, ICH developed in 138 patients, 37 (2.95%) being symptomatic. Mean ages in the ICH and non-ICH groups differed significantly (p=0.041). On- admission- and 24-hours-NIHSS after thrombolysis were higher in ICH patients (p<0.0001). Large vessel occlusion was more prevalent in ICH patients (p=0.0095). The ICH risk was lower after intravenous thrombolysis than intra-arterial or combined thrombolysis (p<0.0001). Both at 3 months and at one year the outcome was worse in ICH patients compared to the non-ICH group (p<0.0001). Mortality and poor outcome were more prevalent in all hemorrhage types with a tendency for massive bleeding associated with unfavorable prognosis. At 3 months with logistic regression model worse outcome was detected in patients with ICH after thrombolysis; at one year in patients with ICH after thrombolysis and smoking. Discussion: Older age, higher NIHSS, large vessel occlusion and intra-arterial thrombolysis may correlate with ICH. Unfavorable outcome is more common in ICH patients. Precise scoring of post-thrombolysis bleeding might be a useful tool in the evaluation of the patients' prognosis. Our findings may help to identify predictors and estimate the prognosis of ICH in patients with AIS treated with rt-PA.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Frontiers in Neurology. - 14 (2023), p. 1-11. -
További szerzők:Héja Máté (1991-) (általános orvos) Márton Sándor (1965-) (matematikus) Tóth Judit (1964-) (radiológus) Horváth László (1973-) (gyógyszerész) Harman Aletta (1984-) (orvos) Fekete István (1951-) (neurológus, pszichiáter)
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

5.

001-es BibID:BIBFORM096522
035-os BibID:(cikkazonosító)757078 (WoS)000717640900001 (Scopus)85118804752
Első szerző:Fekete Klára (neurológus)
Cím:Neurophysiological examinations as adjunctive tool to imaging techniques in spontaneous intracerebral haemorrhage : IRONHEART study / Fekete Klára, Tóth Judit, Horváth László, Márton Sándor, Héja Máté, Csiba László, Árokszállási Tamás, Bagoly Zsuzsa, Sulina Dóra, Fekete István
Dátum:2021
ISSN:1664-2295
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Frontiers in Neurology. - 12 (2021), p. 1-15. -
További szerzők:Tóth Judit (1964-) (radiológus) Horváth László (1973-) (gyógyszerész) Márton Sándor (1965-) (matematikus) Héja Máté (1991-) (általános orvos) Csiba László (1952-) (neurológus, pszichiáter) Árokszállási Tamás (1988-) (neurológus) Bagoly Zsuzsa (1978-) (orvos) Sulina Dóra (PhD hallgató) Fekete István (1951-) (neurológus, pszichiáter)
Pályázati támogatás:K109712
OTKA
K120042
OTKA
FK128582
OTKA
GINOP-2.3.2-15-2016-00043
GINOP
Internet cím:DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

6.

001-es BibID:BIBFORM020672
Első szerző:Frendl Anita (neurológus)
Cím:Pharmacological and non-pharmacological recanalization strategies in acute ischemic stroke / Frendl Anita, Csiba László
Dátum:2011
Megjegyzések:According to the guidelines of the European Stroke Organization (ESO) and the American Stroke Association (ASA), acute stroke patients should be managed at stroke units that include well organized pre- and in-hospital care. In ischemic stroke the restoration of blood flow has to occur within a limited time window that is accomplished by fibrinolytic therapy. Newer generation thrombolytic agents (alteplase, pro-urokinase, reteplase, tenecteplase, desmoteplase) have shorter half-life and are more fibrin-specific. Only alteplase has Food and Drug Administration (FDA) approval for the treatment of acute stroke (1996). The National Institute of Neurological Disorders and Stroke (NINDS) trial proved that alteplase was effective in all subtypes of ischemic strokes within the first 3 h. In the European cooperative acute stroke study III trial, intravenous (IV) alteplase therapy was found to be safe and effective (with some restrictions) if applied within the first 3-4.5 h. In middle cerebral artery (MCA) occlusion additional transcranial Doppler insonication may improve the breakdown of the blood clot. According to the ESO and ASA guidelines, intra-arterial (IA) thrombolysis is an option for recanalization within 6 h of MCA occlusion. Further trials on the IA therapy are needed, as previous studies have involved relatively small number of patients (compared to IV trials) and the optimal IA dose of alteplase has not been determined (20-30 mg is used most commonly in 2 h). Patients undergoing combined (IV + IA) thrombolysis had significantly better outcome than the placebo group or the IV therapy alone in the NINDS trial (Interventional Management of Stroke trials). If thrombolysis fails or it is contraindicated, mechanical devices [e.g., mechanical embolus removal in cerebral ischemia (MERCI)- approved in 2004] might be used to remove the occluding clot. Stenting can also be an option in case of acute internal carotid artery occlusion in the future. An intra-aortic balloon was used to increase the collateral blood flow in the Safety and Efficacy of NeuroFlo(TM) Technology in Ischemic Stroke trial (results are under evaluation). Currently, there is no approved effective neuroprotective drug.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Megjelenés:Frontiers in neurology [electronic resource]. - 2 : 32 (2011), 11p. -
További szerzők:Csiba László (1952-) (neurológus, pszichiáter)
Internet cím:Intézményi repozitóriumban (DEA) tárolt változat
DOI
Borító:

7.

001-es BibID:BIBFORM103012
035-os BibID:(Scopus)85102939985 (WOS)000631262400001 (cikkazonosító)611597
Első szerző:Hayden Zsófia
Cím:Clinical Characteristics and Outcome of Neuronal Surface Antibody-Mediated Autoimmune Encephalitis Patients in a National Cohort / Hayden Zsófia, Bóné Beáta, Orsi Gergely, Szots Monika, Nagy Ferenc, Csépány Tünde, Mezei Zsolt, Rajda Cecília, Simon Diána, Najbauer József, Illes Zsolt, Berki Timea
Dátum:2021
ISSN:1664-2295
Megjegyzések:Background: In our previous single-center study of autoimmune encephalitis (AE) related autoantibody test results we found positivity in 60 patients out of 1,034 with suspected AE from 2012 through 2018 as part of a Hungarian nationwide program. In our current multicenter retrospective study, we analyzed the clinical characteristics and outcome of AE patients with positive neuronal cell surface autoantibody test results. Methods: A standard online questionnaire was used to collect demographic and clinical characteristics, laboratory and imaging data, therapy and prognosis of 30 definitive AE patients in four major clinical centers of the region. Results: In our study, 19 patients were positive for anti-NMDAR (63%), 6 patients (20%) for anti-LGI1, 3 patients for anti-GABABR (10%) and 3 patients for anti-Caspr2 (10%) autoantibodies. Most common prodromal symptoms were fever or flu-like symptoms (10/30, 33%). Main clinical features included psychiatric symptoms (83%), epileptic seizures (73%) and memory loss (50%). 19 patients (63%) presented with signs of central nervous system (CNS) inflammation, which occurred more frequently in elder individuals (p = 0.024), although no significant differences were observed in sex, tumor association, time to diagnosis, prognosis and immunotherapy compared to AE patients without CNS inflammatory markers. Anti-NMDAR encephalitis patients were in more severe condition at the disease onset (p = 0.028), although no significant correlation between mRS score, age, sex and immunotherapy was found. 27% of patients (n = 8) with associated tumors had worse outcome (p = 0.045) than patients without tumor. In most cases, immunotherapy led to clinical improvement of AE patients (80%) who achieved a good outcome (mRS ? 2; median follow-up 33 months). Conclusion: Our study confirms previous publications describing characteristics of AE patients, however, differences were observed in anti-NMDAR encephalitis that showed no association with ovarian teratoma and occurred more frequently among young males. One-third of AE patients lacked signs of inflammation in both CSF and brain MRI, which emphasizes the importance of clinical symptoms and autoantibody testing in diagnostic workflow for early introduction of immunotherapy, which can lead to favorable outcome in AE patients.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Frontiers in Neurology. - 12 (2021), p. 1-11. -
További szerzők:Bóné Beáta Orsi Gergely Szots Monika Nagy Ferenc (neurológus Kaposvár) Csépány Tünde (1956-) (neurológus, pszichiáter) Mezei Zsolt (1979-) (neurológus) Rajda Cecília Simon Diána Najbauer József Illés Zsolt (neurológus, Pécs) Berki Tímea
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

8.

001-es BibID:BIBFORM113079
035-os BibID:(cikazonosító)1233229
Első szerző:Héja Máté (általános orvos)
Cím:Ethylene glycol intoxication presenting as a mimic of acute stroke : report of three cases / Máté Héja, László Oláh
Dátum:2023
ISSN:1664-2295
Megjegyzések:Stroke is a major cause of death and disability presenting with acute focal neurological symptoms of vascular origin. Several other disorders may cause symptoms similar to a stroke, referred as stroke mimics. Misdiagnosis of stroke mimics may lead to potentially harmful treatments, including thrombolysis. Intoxication is a rare, but possible cause of stroke mimic. We present three cases of ethylene glycol poisoning presenting as acute stroke mimic within the time window of thrombolytic therapy. Two of three patients (54-year-old, male) had dysarthria, nystagmus and truncal ataxia on admission. The third patient with a history of chronic alcoholism was presented after an epileptic seizure with mixed aphasia and confusion. NCCT and CTA were negative in all 3 cases. As stroke could not be excluded in any of the patients, thrombolysis was performed. Some hours later agitation, somnolence and hyperventilation developed in 2 of 3 patients. One patient's consciousness deteriorated rapidly, he became comatose and tetraplegic. Blood gas analysis showed acidosis in 2 of 3 patients, and toxicological screening revealed ethylene-glycol intoxication in all 3 cases. Due to the appropriate treatment, 2 of 3 patients became symptom-free, however, one of the 3 patients died. Our cases show that ethylene glycol intoxication in its early phase may mimic acute stroke resulting in an unnecessary thrombolytic therapy. Symptoms not characteristic of a stroke, such as hyperventilation, agitation, and disturbance of consciousness, may appear later and warn of intoxication. The final diagnosis of ethylene-glycol intoxication can be established by a severe metabolic acidosis and toxicological screening. Close monitoring of symptoms might contribute to early recognition of ethylene-glycol intoxication and its effective treatment.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Frontiers in Neurology. - 2 (2023), p. 1-8. -
További szerzők:Oláh László (1967-) (neurológus)
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

9.

001-es BibID:BIBFORM096400
035-os BibID:(cikkazonosító)721337 (WoS)000703262300001 (Scopus)85115841847
Első szerző:Héja Máté (általános orvos)
Cím:Experiences With Intravenous Thrombolysis in Acute Ischemic Stroke by Elderly Patients? : a "Real World Scenario" / Héja Máté, Fekete István, Horváth László, Márton Sándor, Fekete Klára Edit
Dátum:2021
ISSN:1664-2295
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Frontiers in Neurology. - 12 (2021), p. 1-10. -
További szerzők:Fekete István (1951-) (neurológus, pszichiáter) Horváth László (1973-) (gyógyszerész) Márton Sándor (1965-) (matematikus) Fekete Klára (1978-) (neurológus)
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

10.

001-es BibID:BIBFORM078495
035-os BibID:(cikkazonosító)427 (WoS)000466184500001 (Scopus)85067878419 (PMID)31105639
Első szerző:Horváth László (gyógyszerész)
Cím:The outcome of status epilepticus and long-term follow-up / László Horváth, István Fekete, Márk Molnár, Réka Válóczy, Sándor Márton, Klára Fekete
Dátum:2019
ISSN:1664-2295
Megjegyzések:Objective: This study was to investigate the outcome of status epilepticus (SE) associated with antiepileptic therapy during SE and in follow-up period, risk factors including age, co-morbidities, pre-existing epilepsy, and etiology in the East-Hungarian region. Methods: A prospective cross-sectional database was compiled from outpatient files between 2013 and 2017. Follow-up ended on 30.06.2018. Results: One hundred and thirty five episodes (male: 68, 50.4%) were evaluated, mean age and follow-up time being 64.1 +/- 13.9 years and 39.9 +/- 14.2 months, respectively. Of the 89 patients with pre-existing epilepsy, 34 failed to visit the outpatient unit regularly. Case fatality rate was 25.2% and 31 patients (30.7%) died after discharge due to co-morbidities; their mean survival time was 10.44 +/- 8 months. Focal, generalized and combined type epilepsies were diagnosed in 67 patients (49.6%), 47 patients (34.8%), and 21 patients (15.6%) of SE, respectively. Nine patients had non-convulsive SE (NCSE). Mean seizure-free period was 6.8 +/- 6.9 months. Patients taking carbamazepine (20.9%; OR: 0.37, 95% CI: 0.16-0.82; p = 0.018), levetiracetam (27.5%; OR: 0.51, 95% CI: 0.27-0.97; p = 0.041), or valproate (11.1%; OR: 0.18, 95% CI: 0.05-0.61; p = 0.0043) were expected to achieve seizure freedom after SE. The worst outcome was linked to advanced age, etiology, new onset status epilepticus, NCSE, and focal status epilepsy. Conclusion: This study highlights the importance of regular care and patient follow-up.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Frontiers in Neurology. - 10 : 427 (2019), p. 1-8. -
További szerzők:Fekete István (1951-) (neurológus, pszichiáter) Molnár Márk Válóczy Réka Márton Sándor (1965-) (matematikus) Fekete Klára (1978-) (neurológus)
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

11.

001-es BibID:BIBFORM103989
035-os BibID:(scopus)85139560882 (wos)000870013300001 (cikkazonosító)917187
Első szerző:Kelemen Andrea
Cím:Clinical parameters predict the effect of bilateral subthalamic stimulation on dynamic balance parameters during gait in Parkinson's disease / Kelemen Andrea, Halász László, Muthuraman Muthuraman, Erőss Loránd, Barsi Péter, Zádori Dénes, Laczó Bence, Kis Dávid, Klivényi Péter, Fekete Gábor, Bognár László, Bereczki Dániel, Tamás Gertrúd
Dátum:2022
ISSN:1664-2295
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Parkinson, mélyagyi stimuláció
Megjelenés:Frontiers in Neurology. - 13 (2022), p. 1-9. -
További szerzők:Halász László (1989-) (molekuláris biológus) Muthuraman, Muthuraman Erőss Lóránd (1965-) (idegsebész szakorvos) Barsi Péter Zádori Dénes Laczó Bence Kis Dávid Klivényi Péter Fekete Gábor (1979-) (idegsebész) Bognár László (1958-) (idegsebész, gyermekidegsebész) Bereczki Dániel (1960-) (neurológus) Tamás Gertrúd (1975-) (neurológus)
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

12.

001-es BibID:BIBFORM106027
035-os BibID:(cikkazonosító)912664 (scopus)85137215772 (wos)000882813200001
Első szerző:Lóczi Linda
Cím:Thrombin generation as a predictor of outcomes in patients with non-traumatic intracerebral hemorrhage / Lóczi Linda, Orbán-Kálmándi Rita, Árokszállási Tamás, Fekete István, Fekete Klára, Héja Máté, Tóth Judit, Csiba László, Bagoly Zsuzsa
Dátum:2022
ISSN:1664-2295
Megjegyzések:Background: Non-traumatic intracerebral hemorrhage (ICH) accounts for 10-15% of all strokes and leads to a higher rate of mortality as compared to ischemic strokes. We aimed to find out whether the thrombin generation assay (TGA) could predict outcomes in patients with ICH. Patients and methods: In this prospective, observational study, 87 consecutive patients with ICH and 164 healthy controls were included. Computed tomography (CT), detailed clinical investigation, and laboratory investigations were performed from patients on admission. TGA was performed using stored platelet poor plasma obtained on admission. Lag time, endogen thrombin potential (ETP), peak thrombin, and time to peak parameters were calculated. Short- and long-term outcomes of ICH were defined at 14 days and 3 months post-event according to the NIHSS and the modified Rankin Scale (mRS), respectively. Results: Peak thrombin was significantly higher in patients as compared to controls (397.2 ? 93.9 vs. 306 ? 85.3 nM, p < 0.0001). Lag time, ETP, and time to peak parameters showed a significant positive correlation with CRP in both groups. In patients with worse long-term functional outcomes, peak thrombin was significantly higher as compared to those with favorable outcomes [mRS 2-6 median: 402.5 (IQR:344.8-473.8) vs. mRS 0-1: 326.4 (294.2-416.1) nM, p = 0.0096]. Based on the statistically optimal threshold of 339.1 nM peak thrombin, the sensitivity and specificity of this parameter to determine mRS 2-6 as an outcome were 80.8 and 64.7%, respectively. In a binary logistic regression model including age, sex, BMI, smoking status, NIHSS on admission, D-dimer, and peak thrombin (>339.1 nM), only NIHSS and the peak thrombin parameters remained in the model as significant, independent predictors of poor outcome. Lag time and time to peak showed a modest, significant negative correlation with intracerebral bleeding volume on admission (r = -0.2603, p = 0.0231 and r = -0.3698, p = 0.0010, respectively). During the follow-up of patients, estimated hemorrhage volumes on day 90 showed significant positive association with the ETP and peak thrombin parameters (r = 0.3838, p = 0.0363 and r = 0.5383, p = 0.0021, respectively). Conclusion: In patients with ICH, TG was increased as compared to healthy controls, which might be explained by the presence of higher inflammatory parameters in patients. Peak thrombin measured on admission might be a useful tool to predict outcomes in patients with ICH.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Frontiers in Neurology. - 13 (2022), p. 1-12. -
További szerzők:Orbán-Kálmándi Rita Angéla (1993-) (klinikai laboratóriumi kutató) Árokszállási Tamás (1988-) (neurológus) Fekete István (1951-) (neurológus, pszichiáter) Fekete Klára (1978-) (neurológus) Héja Máté (1991-) (általános orvos) Tóth Judit (1964-) (radiológus) Csiba László (1952-) (neurológus, pszichiáter) Bagoly Zsuzsa (1978-) (orvos)
Pályázati támogatás:GINOP-2.3.2-15-2016-00043
GINOP
K120042
OTKA
FK128582
OTKA
ELKH-DE 332 Cerebrovascular and Neurodegenerative Research Group
Egyéb
ÚNKP 20-3-I-DE-220
Egyéb
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Rekordok letöltése1 2 
Corvina könyvtári katalógus v8.2.27 © 2023 Monguz kft. Minden jog fenntartva.